The International Society of Pharmaceutical Engineers (ISPE) and the Parenteral Drug Association (PDA) announced today that they have signed a Memorandum of Understanding (MOU) to exchange information regarding their respective efforts on Quality Metrics and Quality Culture.
ISPE published their Culture Excellence Report in May of 2017 that shared the vision of quality culture improvements across six dimensions and has also collected, analyzed, and published industry survey data that correlates pharmaceutical manufacturing metrics to quality outcomes.
PDA pursued a Quality Culture Assessment to define quality culture attributes and has collected, analyzed and published data and worked to establish a correlation to operational excellence.
Under the MOU, the two organizations agree to share relevant documents developed by their respective quality metrics/culture teams. The MOU leaves open the possibility that ISPE and PDA could directly collaborate on these topics in the future.
The International Society for Pharmaceutical Engineering (ISPE) is the world’s largest not-for-profit association serving its members through leading scientific, technical, and regulatory advancement across the entire pharmaceutical life cycle. The more than 18,500 members of ISPE are building solutions in the development and manufacture of safe, effective pharmaceutical and biologic medicines, and medical delivery devices in more than 90 countries around the world. Founded in 1980, ISPE has its worldwide headquarters in Bethesda, Maryland USA, and an operations and training center in Tampa, Florida USA. Visit www.ISPE.org for more information.
For more information contact:
Senior Director, Marketing Communications
International Society for Pharmaceutical Engineering (ISPE)